中国医师协会骨科大手术后血栓防治专项基金项目课题申报通知

2014-10-21 佚名 中国医师协会

进行骨科大手术(髋关节置换术,膝关节置换术)后的患者静脉血栓栓塞症发病率较高,是围手术期死亡的主要原因之一,也是医院内非预期死亡的主要原因。对骨科大手术患者施以有效的防治方法,如药物预防和物理预防措施等,不仅可以降低发生静脉血栓栓塞症的风险,还可以降低医疗费用。 鉴于骨科大手术后相关血栓栓塞性事件致死致残风险的严峻性,特设立“骨科大手术后血栓防治专项基金”项目,旨在满足骨科中青年优秀医师

进行骨科大手术(髋关节置换术膝关节置换术)后的患者静脉血栓栓塞症发病率较高,是围手术期死亡的主要原因之一,也是医院内非预期死亡的主要原因。对骨科大手术患者施以有效的防治方法,如药物预防和物理预防措施等,不仅可以降低发生静脉血栓栓塞症的风险,还可以降低医疗费用。

鉴于骨科大手术后相关血栓栓塞性事件致死致残风险的严峻性,特设立“骨科大手术后血栓防治专项基金”项目,旨在满足骨科中青年优秀医师的临床科研需求,并借此促进中国骨科大手术后血栓防治领域科研水平的发展。

该项目分2轮进行申报,第一轮课题申报工作将于2014年10月10日-11月25日正式展开,欢迎全国各三级医院骨科中青年医师积极参与相关科研课题的申报,为促进骨科领域的科研进步和临床管理水平的提高做出贡献!

中国医师协会

2014年10月8日

2014 中国医师协会-骨科大手术后血栓防治专项基金申报指南

一、项目时间安排:

项目周期为16个月(2014年7月1日-2015年10月31日),共分4个阶段进行:

1.第一阶段:项目立项、启动,2014年7月-2014年9月

2.第二阶段:第一次评审,2014年9月-2014年12月

3.第三阶段:第二次评审,2015年1月-2015年6月

4.项目追踪结题阶段:2015年6月-2015年10月

二、基金资助对象:

1.三级医院骨科,有髋关节或/和膝关节置换术资格

2.主治医师及以上

3.年龄45岁及以下

4.在骨科大手术后血栓防治领域有一定的科研或临床诊疗经验

三、基金资助课题范围:

具体内容包括(但不限于以下内容):

1.髋关节或膝关节置换术患者血栓预防或治疗相关的基础或临床研究

2.髋关节或膝关节置换术血栓防治相关的流行病学状况调查

3.髋关节或膝关节置换术后血栓防治相关的卫生经济学研究

四、项目申报要求:

1.项目申报必须有明确的研究目的,学术依据,试验流程,资金预算,时间表以及技术,设备,经验和人力资源可行性描述等;

2.项目设计以临床研究为主;

3.项目应具备以下特征:科学性,创新性,实用性和可行性;

4.项目预算一般不超过人民币六万元。基金赞助的费用只能用于该项研究本身,而不得用于差旅或购置的设备。

5.本项目总共评选出15个可以获得资助的优秀课题;

6.项目研究周期一般不得超过1年。

五、申请流程:

1.项目提案申请

申请本基金者请填写附件“2014 中国医师协会-骨科大手术后血栓防治专项基金项目申请表”,以电子邮件和纸质两种形式寄至中国医师协会。申请表打印件必须得到申请人所在医院主管部门的盖章同意。申请人同时对项目的立项,执行负全部法律责任。

2.项目立项评审

收齐申请报告后,专家评审委员会将集中对申请项目进行评审,并在评审会结束后30个工作日内在中国医师协会网站公布评审结果。

六、项目付款说明:

通过项目专家评审委员会审核的课题,中国医师协会将与获得资助的研究者所在医院签订协议,将费用根据项目进度支付给研究者所在的医院。研究者需在费用支付前向中国医师协会提供所在医院的正规发票。中国医师协会有权停止资助不按计划报告进展和项目执行中违反国家法律、项目既定方向的项目。

七、论文著作权:

本基金赞助的研究取得的学术成果如获发表,其著作权归研究者所有。中国医师协会为学术交流目的均有权无偿引用。

八、项目联系人:

联系负责人:王 韬 联系电话:010-64176902

地 址:北京东直门外新中街11号3号楼4层 邮编:100027

项目执行联系人:周 桐

邮寄地址:上海市徐汇区肇嘉浜路446弄 伊泰利大厦1号1502室邮编:200031

联系电话:021-64729901-811 15800617683

电子邮件:zhoutong@clinicalservice.cn


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1663119, encodeId=fc1f166311990, content=<a href='/topic/show?id=fff221e29fd' target=_blank style='color:#2F92EE;'>#中国医师协会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21729, encryptionId=fff221e29fd, topicName=中国医师协会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ce25527825, createdName=ms6897892027066920, createdTime=Sun Apr 26 21:02:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688516, encodeId=fc521688516a5, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Thu Aug 06 13:02:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085618, encodeId=0b61208561872, content=<a href='/topic/show?id=620591986fa' target=_blank style='color:#2F92EE;'>#课题申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91986, encryptionId=620591986fa, topicName=课题申报)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Jul 08 06:02:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977280, encodeId=748519e728095, content=<a href='/topic/show?id=d7e321e287d' target=_blank style='color:#2F92EE;'>#中国医师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21728, encryptionId=d7e321e287d, topicName=中国医师)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Wed Aug 12 20:02:00 CST 2015, time=2015-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1721978, encodeId=1cf21e219783f, content=<a href='/topic/show?id=b73f43e1224' target=_blank style='color:#2F92EE;'>#大手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43712, encryptionId=b73f43e1224, topicName=大手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecc933126179, createdName=Smile2691, createdTime=Thu Oct 01 02:02:00 CST 2015, time=2015-10-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1663119, encodeId=fc1f166311990, content=<a href='/topic/show?id=fff221e29fd' target=_blank style='color:#2F92EE;'>#中国医师协会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21729, encryptionId=fff221e29fd, topicName=中国医师协会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ce25527825, createdName=ms6897892027066920, createdTime=Sun Apr 26 21:02:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688516, encodeId=fc521688516a5, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Thu Aug 06 13:02:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085618, encodeId=0b61208561872, content=<a href='/topic/show?id=620591986fa' target=_blank style='color:#2F92EE;'>#课题申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91986, encryptionId=620591986fa, topicName=课题申报)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Jul 08 06:02:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977280, encodeId=748519e728095, content=<a href='/topic/show?id=d7e321e287d' target=_blank style='color:#2F92EE;'>#中国医师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21728, encryptionId=d7e321e287d, topicName=中国医师)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Wed Aug 12 20:02:00 CST 2015, time=2015-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1721978, encodeId=1cf21e219783f, content=<a href='/topic/show?id=b73f43e1224' target=_blank style='color:#2F92EE;'>#大手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43712, encryptionId=b73f43e1224, topicName=大手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecc933126179, createdName=Smile2691, createdTime=Thu Oct 01 02:02:00 CST 2015, time=2015-10-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1663119, encodeId=fc1f166311990, content=<a href='/topic/show?id=fff221e29fd' target=_blank style='color:#2F92EE;'>#中国医师协会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21729, encryptionId=fff221e29fd, topicName=中国医师协会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ce25527825, createdName=ms6897892027066920, createdTime=Sun Apr 26 21:02:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688516, encodeId=fc521688516a5, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Thu Aug 06 13:02:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085618, encodeId=0b61208561872, content=<a href='/topic/show?id=620591986fa' target=_blank style='color:#2F92EE;'>#课题申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91986, encryptionId=620591986fa, topicName=课题申报)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Jul 08 06:02:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977280, encodeId=748519e728095, content=<a href='/topic/show?id=d7e321e287d' target=_blank style='color:#2F92EE;'>#中国医师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21728, encryptionId=d7e321e287d, topicName=中国医师)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Wed Aug 12 20:02:00 CST 2015, time=2015-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1721978, encodeId=1cf21e219783f, content=<a href='/topic/show?id=b73f43e1224' target=_blank style='color:#2F92EE;'>#大手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43712, encryptionId=b73f43e1224, topicName=大手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecc933126179, createdName=Smile2691, createdTime=Thu Oct 01 02:02:00 CST 2015, time=2015-10-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1663119, encodeId=fc1f166311990, content=<a href='/topic/show?id=fff221e29fd' target=_blank style='color:#2F92EE;'>#中国医师协会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21729, encryptionId=fff221e29fd, topicName=中国医师协会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ce25527825, createdName=ms6897892027066920, createdTime=Sun Apr 26 21:02:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688516, encodeId=fc521688516a5, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Thu Aug 06 13:02:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085618, encodeId=0b61208561872, content=<a href='/topic/show?id=620591986fa' target=_blank style='color:#2F92EE;'>#课题申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91986, encryptionId=620591986fa, topicName=课题申报)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Jul 08 06:02:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977280, encodeId=748519e728095, content=<a href='/topic/show?id=d7e321e287d' target=_blank style='color:#2F92EE;'>#中国医师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21728, encryptionId=d7e321e287d, topicName=中国医师)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Wed Aug 12 20:02:00 CST 2015, time=2015-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1721978, encodeId=1cf21e219783f, content=<a href='/topic/show?id=b73f43e1224' target=_blank style='color:#2F92EE;'>#大手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43712, encryptionId=b73f43e1224, topicName=大手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecc933126179, createdName=Smile2691, createdTime=Thu Oct 01 02:02:00 CST 2015, time=2015-10-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1663119, encodeId=fc1f166311990, content=<a href='/topic/show?id=fff221e29fd' target=_blank style='color:#2F92EE;'>#中国医师协会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21729, encryptionId=fff221e29fd, topicName=中国医师协会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9ce25527825, createdName=ms6897892027066920, createdTime=Sun Apr 26 21:02:00 CST 2015, time=2015-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1688516, encodeId=fc521688516a5, content=<a href='/topic/show?id=327b699645c' target=_blank style='color:#2F92EE;'>#申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69964, encryptionId=327b699645c, topicName=申报)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1a1628602102, createdName=1508842480_96220446, createdTime=Thu Aug 06 13:02:00 CST 2015, time=2015-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2085618, encodeId=0b61208561872, content=<a href='/topic/show?id=620591986fa' target=_blank style='color:#2F92EE;'>#课题申报#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91986, encryptionId=620591986fa, topicName=课题申报)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Jul 08 06:02:00 CST 2015, time=2015-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1977280, encodeId=748519e728095, content=<a href='/topic/show?id=d7e321e287d' target=_blank style='color:#2F92EE;'>#中国医师#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21728, encryptionId=d7e321e287d, topicName=中国医师)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=373a131, createdName=jxrzshh, createdTime=Wed Aug 12 20:02:00 CST 2015, time=2015-08-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1721978, encodeId=1cf21e219783f, content=<a href='/topic/show?id=b73f43e1224' target=_blank style='color:#2F92EE;'>#大手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43712, encryptionId=b73f43e1224, topicName=大手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ecc933126179, createdName=Smile2691, createdTime=Thu Oct 01 02:02:00 CST 2015, time=2015-10-01, status=1, ipAttribution=)]

相关资讯

BJJ:老年人半髋置换用骨水泥还是非骨水泥?

髋关节骨折是一种常见于老年患者的严重创伤,据估计,其发生率会在未来20年中持续增长。对于关节囊内的移位性股骨颈骨折常需要选择行半髋置换术,很多全国性的临床指南推荐骨水泥型半髋关节假体。而为了避免骨水泥带来的死亡率和并发症,有着严重合并症的病例往往对选择非骨水泥型假体。 过去的文献在这方面报道的结果一直存在争议。有少数患者甚至在术后短期就会发生死亡,但相关的研究往往又受到样本量的限制。来自

BMJ综述:儿童股骨头骨骺缺血性坏死

什么是Perthes病? Perthes病临床表现为自发的股骨头骨骺缺血,多为骨骺由单一旋股外侧动脉供血的处于4~12岁的儿童患病。每年小于15岁儿童的Perthes病发病率在0.0002%~0.0191%之间。其中双侧髋关节同时发病的约占15%,但通常双侧受累程度不同。男孩儿的发病率约是女孩儿的3~4倍。 该病好发于:低出生体重儿、孕期母亲吸烟、低社会经济人群、白种人。发病儿童多

CORR:滑膜活检诊断髋关节假体感染准确率高

髋关节假体感染文献报道其发生率约1-3%,是髋关节置换术后最为严重的并发症,因此对关节置换术后存在髋关节假体松动或疼痛的患者术前准确的诊断是否存在感染非常重要。髋关节假体晚期感染和早期感染不同,有些患者并没有感染的典型临床表现,这给临床诊断带来了一定的困难。美国骨科医师协会(AAOS)工作组在其发布的一项指南中[美国感染协会PJI(假体感染)诊断及治疗指南]认为关节腔内抽液及CRP检查是诊断PJI

Lancet:近8年THA术后90天死亡率下降一半

9月28期的Lancet发表了一篇文章,对威尔士和英格兰地区超过40万例髋关节置换术后患者进行的研究发现,通过采用4种临床管理策略,患者90天的死亡率下降了一半。来自英国布里斯托大学临床科学院的Linda P. Hunt博士,肌肉骨骼研究组副研究员,她和同事们对英格兰和威尔士的国家关节置换登记注册中心的数据进行了分析,该中心与国家死亡数据库和医院统计数据库相关联。2003年4月和2011年12月期